Newsletters

[alexed]

The Stock Genie's DECEMBER NEW'S ALERT
CONGRATULATION'S to all of the STOCK GENIE'S valued subscriber's, for
using last week's management update on NTSE. Updated on 12/12/00 @ $0.78,
Today, NTSE closed @ $1.15 up almost 50 PERCENT in less than 1 week

**************************************************************

ABOUT NEWS ALERT:

The Stock Genie has been asked by many company's to distribute their press
releases to Stock Genie's valued subscriber's, via e-mail, without Stock
Genie doing a profile on such company. The content of such NEW'S ALERT'S,
for the most part, will be as follows: Management will provide all
information, including press release, profile page and a short about
themselves. WE hope our valued members find this information informative.

*************DECEMBER NEW'S ALERT*****************************

STOCK GENIE'S NEWS ALERT:
AMERINETGROUP.COM, INC.
OTC SYMBOL: ABUY
TODAY'S CLOSING BID: $0.20
52 Week High:$2.125
52 Week Low:$0.17
SHARES OUTSTANDING: 12,500,000
PUBLIC FLOAT: APPROX. 4,500,000
Market Cap.:$2,500,000
************************************************************

Subject: ABUY Update : AmeriNet Group OTC BB ABUY


ABUY has based and may be ready for a runup

ABUY re-positions itself to enter the Multi Billion Dollar
Health-Care information technology sector

ABUY signs letter of intent to acquire PriMed Technologies
www.primedtech.com (total solution provider to the Health Care Industry)

ABUY has obtained a report from Venture One Capital (division of Reuters)
that valued similar companies at over $18 Million , ABUY is acquiring for
a fraction of this (making ABUY undervalued)

ABUY will partly be in a sector that is recession proof

ABUY with PriMed will have wireless technology that will change
prescription writing in the health care industry

ABUY considering changing its name to better reflect its new direction

ABUY currently has two operating subsidiaries, AmeriNet
Communications(full service advertising agency) and WriWebs who
specializes in website hosting, website design and provides e-commerce and
internet solutions

ABUY has an19% investment interest in www.healthpetnet.com and
www.vistavacations.com

ABUY is virtually debt free, with the addition of PriMed and ABUYs
Consulting Assistant Program that gives ABUY shareholders stock in other
public companies that they assist in going public at no cost or obligation
to shareholders

ABUY website is www.amerinetgroup.com 00,000 MARKET CAPLITALIZATION:
APPROX. $2,500,000

*******************TODAY'S ABUY PRESS RELEASE*********************

Monday December 18, 4:01 pm Eastern Time
Press Release
SOURCE: AmeriNet Group.com, Inc.

AmeriNet Enters Multi-Billion Dollar Information Technology Industry

Boca Raton Florida: AmeriNet Group.com, Inc., (AmeriNet) (OTC
Bulletin Board, ABUY) announced that it has entered into a letter of
intent to acquire PriMed Technologies, Inc. (PriMed), an information
technology company specializing in the healthcare sector (a market
comprised of over 1,000,000 healthcare professionals in the United States
with over 15,000 physicians in South Florida alone). During the 1999
calendar year, venture capitalists invested more than $20 billion in
information technology companies, according to VentureOne Corp., a wholly
owned subsidiary of Reuters (VentureOne). VentureOne has prepared a
valuation report for PriMed, a detailed copy of which will be available on
the PriMed website at www.primedtech.com. <http://www.primedtech.com>

PriMed is headquartered in Deerfield Beach, Florida, with its
current base of clients spanning the Palm Beach, Broward and Dade
tri-county area. PriMed provides value-added services such as web-enabled
applications, online medical records management and financial consulting.
Through industry alliances, PriMed provides its clients with state of the
art digital dictation and wireless order entry, pharmacy & laboratory
services. The wireless information services market is expected to reach
$1.8 trillion by 2005, as reported by The Gartner Group, a technology
research firm.

Commenting on PriMeds exciting growth potential and demonstrated
ability to successfully integrate business innovation with unique
information technology breakthroughs, AmeriNets President, Lawrence R.
Van Etten, observed that this new trend in managing and applying the
latest business innovations resolves major management concerns in the
healthcare profession.

PriMed Technologies, Inc., established in 1993, provides proven
management and financial expertise along with the latest on-line
technologies to its growing client base of physicians, hospitals and
ancillary service organizations in South Florida. Regional and nationwide
expansion is planned over the next 24 months. Revenue projections for the
coming fiscal year provided to AmeriNet by PriMeds management are
forecasted to exceed 3 million.

Simply stated, PriMeds core business provides healthcare
professionals with the tools that allow them to see more patients
efficiently, provide stronger accounts receivable management and prevent
the risk of malpractice litigation, stated Evan Brovenick, PriMeds
president and CEO.

The parties are in the process of drafting definitive acquisition
documents and it is anticipated that the transaction will involve the
acquisition of all of PriMeds assets and assumption of designated
liabilities, including a $145,000 liability to the United States Internal
Revenue service, by two organized AmeriNet subsidiaries, one of which will
continue PriMeds operations and the second will continue PriMeds
software development activities. It is anticipated that the acquisition
will be effected in exchange for 1,000,000 shares of AmeriNets common
stock. Subject to attainment of up to $ 4,175,000 in cumulative net,
pre-tax profits during the four fiscal year period ending on June 30,
2004, up to 11,500,000 additional shares of AmeriNets common stock would
be issuable to PriMed executive officers, who will become the principle
executive officers and directors of the new AmeriNet subsidiaries. The
parties hope to complete the acquisition by January 15, 2001, however, no
assurances can be provided that such goal can be attained, or that the
parties will be able to agree on the terms of definitive agreements. In
the event that the parties fail for any reason and regardless of fault, to
enter into or close upon a definitive agreement, then PriMed will register
with the Commission on Form SB-2 (or, if available, Form SB-1) for
issuance directly to AmeriNets stockholders, at PriMeds expense, shares
in an amount measured after issuance, equal to 10% of PriMeds outstanding
and reserved common stock. PriMed would become its own public company
with AmeriNet shareholders having free trading shares therein.

AmeriNet is a publicly traded holding company, which files
periodic reports with the Securities and Exchange Commission. It has
offices in Ocala and Boca Raton, Florida. In business since 1964, its
management has a collective wealth of expertise in finance, acquisitions
and securing growth capital for emerging companies in the medical,
Internet and hi-tech fields. Its subsidiaries currently include:
Wriwebs.com, Inc., and AmeriNet Communications, Inc.

For additional information contact:

Charles J. Scimeca at [phone] (voice); [phone]
<[e-mail]>


This release is comprised of inter-related information that must be
interpreted in the context of all of the information provided and care
should be exercised not to consider portions of this release out of
context. This release contains certain forward-looking statements and
information (as defined in the Private Securities Litigation Reform Act
of 1995) concerning AmeriNet that are based on the beliefs of AmeriNets
management, as well as assumptions made by and information currently
available to AmeriNet. Such statements reflect the current views of
AmeriNet with respect to future events and are subject to certain
assumptions, including those described in this release. Should one or
more of the underlying assumptions prove incorrect, actual results may
vary materially from those described herein as anticipated, believed or
expected. AmeriNet does not intend to update these forward-looking
statements prior to announcement of quarterly or annual
results.speculative nature of the companies profiled.



******************************************************************
Disclaimer

The Stock Genie is an independent electronic publication providing
information on selected public companies. Certain companies profiled by
Stock Genie pay consideration in cash and/or stock to Stock Genie for the
electronic dissemination of company information and, in some cases, web
site development. Stock Genie has been retained as a consultant to K.
Walker Limited for six months, pursuant to a written agreement which
provides for the payment for its services, including the electronic
dissemination of information concerning Amerinet Group.Com Inc. As
consideration, Stock Genie and its agents and/or affiliates will receive
up to 180,000 free trading shares of Amerinet payable in installments over
the next six months. Stock Genie did not receive any other compensation,
of any kind, for its services. Stock Genie is not a registered investment
advisor or a broker dealer. Stock Genie has been advised that the
investments in companies profiled are considered to be high risk and use
of the information provided is at the investors sole risk. Stock Genie
has also been advised that the purchase of such high risk securities may
result in the loss of some or all of the investment. The information
provided by the profiled companies may include information provided by
outside sources, such as research reports, public filings or computer
databases and information provided to Stock Genie by management of the
profiled company. All information is provided by the companies profiled
and Stock Genie makes no representations, warranties or guarantees as to
the accuracy or completeness of the disclosure by the profiled companies.
Investors should not rely solely on the information presented. Rather,
investors should use the information provided by the profiled companies as
a starting point for doing additional independent research on the profiled
companies in order to allow the investor to form his or her own opinion
regarding investing in the profiled companies. Factual statements made by
the profiled companies are made as of the date stated and are subject to
change without notice. The receipt of this information shall not create,
under any circumstances, any implication that there has been no change in
the affairs of the company profiled since the date of review. Investing in
micro-cap securities is highly speculative and carries an extremely high
degree of risk. It is possible that an investors entire investment may be
lost or impaired due to the speculative nature of the companies profiled.
Stock Genie makes no recommendation that the securities of the companies
profiled should be purchased, sold or held by individuals or entities that
learn of the profiled companies through Stock Genie. Investing in
micro-cap securities is highly speculative and carries an extremely high
degree of risk. It is possible that an investors investment may be lost
or impaired due to the speculative nature of the companies profiled